Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius M Hoeper

Showing results (281-290 of 311) with videos related to

Pageof 32
Sort By:
The New England Journal of Medicine|September 30, 2025
Sotatercept for Pulmonary Arterial Hypertension within the First Year after DiagnosisVallerie V McLaughlin, Marius M Hoeper, David B Badesch, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertensionNicholas S Hill, Hunter Gillies, Murali M Chakinala, et al.
Immunity|February 10, 2021
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responsesAgnes Bonifacius, Sabine Tischer-Zimmermann, Anna C Dragon, et al.
Circulation|January 31, 2016
Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective RegistryMarion Delcroix, Irene Lang, Joanna Pepke-Zaba, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 9, 2018
Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertensionManuel J Richter, Satenik Harutyunova, Tom Bollmann, et al.
Journal of Thrombosis and Thrombolysis|September 1, 2016
Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort studyStavros V Konstantinides, Stefano Barco, Stephan Rosenkranz, et al.
Chest|February 13, 2021
Pulmonary Hypertension in Patients With COPD: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Carmine Dario Vizza, Marius M Hoeper, Doerte Huscher, et al.
Nature Immunology|January 14, 2026
A distinct monocyte transcriptional state links systemic immune dysregulation to pulmonary impairment in long COVIDSaumya Kumar, Chaofan Li, Liang Zhou, et al.
The New England Journal of Medicine|April 1, 2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for DeathMarc Humbert, Vallerie V McLaughlin, David B Badesch, et al.
International Journal of Cardiology|November 21, 2012
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registryMarius M Hoeper, Doerte Huscher, H Ardeschir Ghofrani, et al.
Pageof 32

Showing results (281-290 of 311) with videos related to

Sort By:
Pageof 32
The New England Journal of Medicine|September 30, 2025
Sotatercept for Pulmonary Arterial Hypertension within the First Year after DiagnosisVallerie V McLaughlin, Marius M Hoeper, David B Badesch, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertensionNicholas S Hill, Hunter Gillies, Murali M Chakinala, et al.
Immunity|February 10, 2021
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responsesAgnes Bonifacius, Sabine Tischer-Zimmermann, Anna C Dragon, et al.
Circulation|January 31, 2016
Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective RegistryMarion Delcroix, Irene Lang, Joanna Pepke-Zaba, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 9, 2018
Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertensionManuel J Richter, Satenik Harutyunova, Tom Bollmann, et al.
Journal of Thrombosis and Thrombolysis|September 1, 2016
Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort studyStavros V Konstantinides, Stefano Barco, Stephan Rosenkranz, et al.
Chest|February 13, 2021
Pulmonary Hypertension in Patients With COPD: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Carmine Dario Vizza, Marius M Hoeper, Doerte Huscher, et al.
Nature Immunology|January 14, 2026
A distinct monocyte transcriptional state links systemic immune dysregulation to pulmonary impairment in long COVIDSaumya Kumar, Chaofan Li, Liang Zhou, et al.
The New England Journal of Medicine|April 1, 2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for DeathMarc Humbert, Vallerie V McLaughlin, David B Badesch, et al.
International Journal of Cardiology|November 21, 2012
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registryMarius M Hoeper, Doerte Huscher, H Ardeschir Ghofrani, et al.
Pageof 32